MBRX stock

Moleculin Biotech Inc (MBRX) financials · $8.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Moleculin Biotech Inc (MBRX) $8.2M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/AN/A
Operating Income-$25.1M-$26.6M
Net Income-$33.6M-$21.8M
EPS (Diluted)-$28.42-$6.32
Cached annual balance sheet
LineFY2025FY2024
Total Assets$22.1M$16.9M
Current Assets$9.69M$5.19M
Cash & Equivalents$8.88M$4.28M
PP&E$78.0K$159.0K
Total Liabilities$7.12M$10.9M
Current Liabilities$6.85M$5.36M
Shareholders' Equity$15.0M$5.98M
Retained Earnings-$206.0M-$153.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$22.7M-$23.9M
CapExN/A$13.0K
Investing Cash FlowN/A-$13.0K
Financing Cash Flow$27.3M$4.63M
Net Change in Cash$4.60M-$19.3M
Free Cash Flow-$22.7M-$23.9M
These statements as JSON? API free 100/day

FAQ

What is MBRX P/E and revenue?

Moleculin Biotech Inc (MBRX) $8.2M cap.

What is MBRX revenue?

MBRX income-statement cache has no revenue figure yet.

Is MBRX profitable?

Moleculin Biotech Inc last cached net income is -$33.6M (FY2025).

What are MBRX total assets?

Moleculin Biotech Inc last cached total assets are $22.1M (FY2025).

What is MBRX free cash flow?

Moleculin Biotech Inc last cached free cash flow is -$22.7M (FY2025).

Not investment advice. Cached statements, not a live tape.